<!DOCTYPE html><html lang="en"><head><meta name="generator" content="Scully 0.0.0">
  <meta charset="utf-8">
  <title>NgxGardSkully 123</title>
  <base href="/">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <link rel="icon" type="image/x-icon" href="favicon.ico">
<link rel="stylesheet" href="styles.4cdd1989b7928c8b693d.css"><style>body,html{overflow-x:hidden}@media (max-width:991.98px){.offcanvas-collapse{position:fixed;top:56px;bottom:0;left:100%;width:100%;padding-right:1rem;padding-left:1rem;overflow-y:auto;visibility:hidden;background-color:#343a40;transition:transform .3s ease-in-out,visibility .3s ease-in-out}.offcanvas-collapse.open{visibility:visible;transform:translateX(-100%)}}.nav-scroller{position:relative;z-index:2;height:2.75rem;overflow-y:hidden}.nav-scroller .nav{display:flex;flex-wrap:nowrap;padding-bottom:1rem;margin-top:-1px;overflow-x:auto;color:hsla(0,0%,100%,.75);text-align:center;white-space:nowrap;-webkit-overflow-scrolling:touch}.nav-underline .nav-link{padding-top:.75rem;padding-bottom:.75rem;font-size:.875rem;color:#6c757d}.nav-underline .nav-link:hover{color:#007bff}.nav-underline .active{font-weight:500;color:#343a40}.text-white-50{color:hsla(0,0%,100%,.5)}.bg-purple{background-color:#6f42c1}.lh-100{line-height:1}.lh-125{line-height:1.25}.lh-150{line-height:1.5}.splitter{margin-left:20px;margin-right:20px;display:inline-block;font-size:20px;transform:scaleX(.3)}.banner{background-color:#1b5b76;height:116px;background-image:url(https://rarediseases.info.nih.gov/content/images/banner-touch-diseases.jpg);background-repeat:no-repeat;background-position:100%}.search-ct{top:40px;left:30px}.footer{background:#d3d3d3;height:230px}.footer-links{padding-top:20px}.footer-text{margin-top:30px;text-align:center}.input-group-text{cursor:pointer}</style><style></style><script>window['ScullyIO']='generated';</script><script>window.ScullyIOAngularDisabled = true;</script></head>
<body scully-version="0.0.0">
  <app-root ng-version="10.0.14"><nav class="navbar navbar-dark sticky-top bg-dark flex-md-nowrap p-0 shadow"><span class="shrink-width"><ul class="navbar-nav px-3 list-inline"><li class="nav-item text-nowrap list-inline-item"><span href="#" class="nav-link">U.S. Department of Health &amp; Human Services <span class="splitter"> &gt; </span> National Institutes of Health <span class="splitter"> &gt; </span> NCATS</span></li></ul></span></nav><div class="shrink-width"><div class="nav-scroller bg-white shadow-sm justify-content-center"><nav class="nav nav-underline"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases">Diseases</a><a routerlink="/help" routerlinkactive="active" class="nav-link" href="/help">Guides</a><a routerlink="/about" routerlinkactive="active" class="nav-link" href="/about">News</a><a routerlink="/glossary" routerlinkactive="active" class="nav-link" href="/glossary">About GARD</a><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases">En Espanõl</a></nav></div><form novalidate="" class="ng-untouched ng-pristine ng-valid"><div class="banner"><div class="col-md-6 search-ct"><div class="input-group mb-3"><input formcontrolname="search" type="text" placeholder="Search for Diseases, Organizations, News and More..." aria-label="Search for Diseases, Organizations, News and More..." aria-describedby="basic-addon2" class="form-control ng-untouched ng-pristine ng-valid"><span class="input-group-text">GO</span></div></div></div></form><div class="container-fluid"><router-outlet></router-outlet><app-disease-details><div class="row"><div class="col-md-3"><nav><div class="sidebar-sticky pt-3"><ul class="nav flex-column"><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> Browse A-Z </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> Find Diseases By Category </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> List of FDA Orphan Drugs </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> GARD Information Navigator </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> FAQs About Rare Diseases </a></li></ul></div></nav></div><main role="main" class="col-md-9"><div class="d-flex justify-content-between flex-wrap flex-md-nowrap align-items-center pt-3 pb-2 mb-3 border-bottom"><h1 class="h2">Disease # 2658 - Tyrosinemia type 1</h1></div><div><p><b>Other Names: </b>Tyrosinemia type I, Hepatorenal tyrosinemia, Fumarylacetoacetase deficiency, FAH deficiency</p><p><b>Categories: </b><span> Congenital and Genetic Diseases</span><span> Digestive Diseases</span><span> Kidney and Urinary Diseases</span><span> Metabolic disorders</span><span> Nervous System Diseases</span><span> Newborn Screening</span><span> Rare Cancers</span><!----></p><p><b>This disease is grouped under: </b></p><p><b>Summary: </b><span><strong>Tyrosinemia type&nbsp;1</strong> is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. This condition is caused by&nbsp;a shortage of the <a href="http://www.genome.gov/glossary/index.cfm?id=58" target="_blank">enzyme</a> fumarylacetoacetate hydrolase, one&nbsp;of the enzymes required for the multi-step process that breaks down tyrosine.&nbsp;This enzyme shortage is caused by <a href="http://www.genome.gov/glossary/index.cfm?id=134" target="_blank">mutations</a> in the <a href="http://ghr.nlm.nih.gov/gene=fah" target="_blank"><em>FAH</em></a> <a href="http://www.genome.gov/glossary/index.cfm?id=70" target="_blank">gene</a>. Symptoms usually appear in the first few months of life and include <a href="http://www.nlm.nih.gov/medlineplus/ency/article/000991.htm" target="_blank">failure to thrive</a>, diarrhea, vomiting, <a href="http://www.nlm.nih.gov/medlineplus/jaundice.html" target="_blank">jaundice</a>, cabbage-like odor, and increased tendency to bleed (particularly nosebleeds). Tyrosinemia type I&nbsp;can lead to liver and kidney failure, softening and weakening of the bones, problems affecting the nervous system, and an increased risk of liver cancer. This condition is inherited in an <a href="http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm" target="_blank">autosomal recessive</a> manner.[2000] Treatment should be started as soon as the condition is diagnosed and includes a diet restricted in tyrosine and phenylalanine along with nitisinone, a medication that blocks the second step in the tyrosine degradation pathway.[2331][14187]&nbsp; &nbsp;</span></p><div><b>Organizations: </b><ul><li><span><a href="org.url">Tyrosinemia Society, Inc</a></span><br><span>P.O. Box 11340</span><br><span>Huntsville AL, 35814</span><br><!----><!----></li><!----></ul></div><div><b>Learn More</b><ul><li><span><a href="http://www.omim.org/276700" target="_blank">Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br>
</span></li><li><span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=tyrosinemia+type+1+%5Bti%5D" target="_blank">PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Tyrosinemia type 1. Click on the link to view a sample search on this topic.</span></li><li><span><a href="http://www.clinicaltrials.gov/ct2/results?cond=%22Tyrosinemia+type+1%22" target="_blank">ClinicalTrials.gov</a> lists trials that are related to Tyrosinemia type 1. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br>
<br>
<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em></span></li><li><span><a href="http://ghr.nlm.nih.gov/condition=tyrosinemia" target="_blank">Genetics Home Reference (GHR)</a> contains information on Tyrosinemia type 1. This website is maintained by the National Library of Medicine.<br>
</span></li><li><span><a href="https://www.babysfirsttest.org/newborn-screening/conditions/tyrosinemia-type-i" target="_blank">Baby's First Test</a> is the nation's newborn screening education center for families and providers. This site provides information and resources about screening at the local, state, and national levels and serves as the Clearinghouse for newborn screening information.</span></li><li><span><a href="https://www.newbornscreening.info/iva-isovaleric-acidemia/" target="_blank">National Newborn Screening and Global Resource Center</a> (NNSGRC) provides information and resources in the area of newborn screening and genetics to benefit health professionals, the public health community, consumers and government officials.</span></li><li><span>To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href="http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx" target="_blank">American College of Medical Genetics</a> and the&nbsp;<a href="https://www.findageneticcounselor.com/" target="_blank">National Society of Genetic Counselors</a>. If you need additional help, <a href="https://rarediseases.info.nih.gov/about-gard/contact-gard">contact a GARD Information Specialist</a>. You can also&nbsp;<a href="https://ghr.nlm.nih.gov/primer#consult" target="_blank">learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.</span></li><li><span>The <a href="https://rarediseases.org/rare-diseases/tyrosinemia-type-1/" target="_blank">National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br>
</span></li><li><span><a href="http://emedicine.medscape.com/article/949816-overview" target="_blank">Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br>
</span></li><li><span><a href="http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=882" target="_blank">Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br>
</span></li><li><span>An  <a href="https://www.acmg.net/PDFLibrary/Tyrosine.pdf" target="_blank">ACTion (ACT) sheet </a> is available for this condition that describes the short-term actions a health professional should follow when an infant has a positive newborn screening result. ACT sheets were developed by experts in collaboration with the American College of Medical Genetics.</span></li><li><span><a href="http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&amp;part=tyrosinemia" target="_blank">GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br>
</span></li><li><span><a href="https://meshb.nlm.nih.gov/record/ui?ui=D020176" target="_blank">MeSH®</a> (Medical Subject Headings) is a terminology tool used by the National Library of Medicine. Click on the link to view information on this topic.</span></li><li><span>An <a href="https://www.acmg.net/PDFLibrary/Tryosine-Elevated-Algorithm.pdf" target="_blank">Algorithm</a> flowchart is available for this condition for determining the final diagnosis in an infant with a positive newborn screening result. Algorithms are developed by experts in collaboration with the American College of Medical Genetics.</span></li><li><span>The <a href="http://www.newbornscreening.info/Parents/aminoaciddisorders/Tyrosinemia.html" target="_blank">Screening, Technology And Research in Genetics (STAR-G) Project</a> has a fact sheet on this condition, which was written specifically for families that have received a diagnosis as a result of newborn screening. This fact sheet provides general information about the condition and answers questions that are of particular concern to parents.</span></li><li><span>The <a href="https://monarchinitiative.org/disease/OMIM:276700" target="_blank">Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch’s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.</span></li><!----></ul></div></div></main><!----></div></app-disease-details><!----></div></div><div class="footer"><div class="shrink-width"><div class="footer-links row align-items-center"><div class="col"><a href="/" target="_self">GARD Home</a></div><div class="col"><a href="http://ncats.nih.gov/" target="_blank">NCATS Home</a></div><div class="col"><a href="/sitemap" target="_self">Site Map</a></div><div class="col"><a href="/glossary" target="_self">Browse Glossary A-Z</a></div><div class="col"><a href="/pages/36/privacy-notice" target="_self">Privacy Notice</a></div><div class="col"><a href="/pages/37/disclaimer" target="_self">Disclaimer</a></div><div class="col"><a href="/pages/38/accessibility" target="_self">Accessibility</a></div><div class="col"><a href="/pages/39/foia" target="_self">FOIA </a></div><div class="col"><a href="http://oig.hhs.gov/" target="_blank">OIG</a></div></div><div class="footer-text"><p> If you have problems viewing PDF files, download the latest version of <a target="_blank" href="https://get.adobe.com/reader/" class="footer-links">Adobe Reader</a></p><p> For <a f="http://edi.nih.gov/consulting/language-access-program/about" target="_blank" title="Read the plan" class="ext">language access</a> assistance, contact the <a href="mailto: info@ncats.nih.gov" title="E - mail Public Information Officer" class="footer-links">NCATS Public Information Officer</a></p><p> Genetic and Rare Diseases Information Center (GARD) - PO Box 8126, Gaithersburg, MD 20898-8126 - Toll-free: 1-888-205-2311 </p></div></div></div></app-root>

<script src="js/custom.js"></script>

</body></html>